Kingiodendron pinnatum, a pharmacologically effective alternative for Saraca asoca in an Ayurvedic preparation, Asokarishta

10.1016/j.jtcme.2017.06.005

Adangam Purath Shahid；Nanu Sasidharan；Sasidharan Salini；Jose Padikkala；Nair Meera；Achuthan Chathrattil Raghavamenon；Thekkekara Devassy Babu

Asokarishta ； Substitutes ； Anti-estrogenic ； Anti-inflammatory ； Uterus endometrium ； Cornification ； Metaplasia

Journal of Traditional and Complementary Medicine

8卷1期（2018 / 01 / 01）

244 - 250

英文

Saraca asoca (Fabaceae) is a prime ingredient in Asokarishta, a well-known Ayurvedic preparation for gynecological ailments. Due to scarcity, adulteration or substitution of related raw drugs is a common practice in its preparation. The bark of Kingiodendron pinnatum (Roxb. ex DC.) Harms, morphologically similar to S. asoca (Asoka) is a widely used substitute. The present study aimed to evaluate the pharmacological effectiveness of K. pinnatum as an alternative for S. asoca in Asokarishta by determining the inhibitory effect of estrogen induced uterus endometrial thickening in immature female rats. Arishta was prepared using S. asoca and with the substitute, K. pinnatum as per Ayurvedic Pharmacopeia. Uterus endometrial thickening was induced by the administration of estradiol (20 μg/kg b. wt, i.p) to 8-day-old rats for 5 alternate days. On day 16, following estradiol administration, the serum estrogen level was found elevated to 156.5 ± 8 pg/ml from the normal value 32.4 ± 5 pg/ml and consequently increased the thickness of uterus endometrium from 16.7 ± 1.4 to 75.2 ± 15.3 μm. Upon oral administration of 400 μl/ kg b. wt Asokarishta (ASA) and Arishta made with K. pinnatum (AKP), the thickening was reduced to 42.5 ± 12.7 and 47.1 ± 10.5 μm and the estrogen level diminished to 102.6 ± 10 and 97.3 ± 8 pg/ml, respectively. Arishta also reduced the chronic/acute inflammations in mice and improved the antioxidant status of rats. No toxic symptom was observed in the animals by the treatment of Arishta. The study supports the use of K. pinnatum as an alternative to S. asoca in Asokarishta and gives a scientific validation for Asokarishta in gynecological ailments.

1. Pushpendra Kumar, KNS,Priyadarshini Holla, BS,Ravishankar, B,Yashovarma, B(2016).Quality standards for Hutabhugadi curṇa (Ayurvedic formulary of India).J Tradit Complement Med.,6(1),78-88.
   連結：
2. Ahmad, F,Misra, L,Tewari, R,Gupta, P,Mishra, P,Shukla, R(2016).Anti-inflammatory flavanol glycosides from Saraca asoca bark.Nat Prod Res,30(4),489-492.
3. Anjan, BN,Hombe, GHC,Vasudeva, R(2004).A note on air layering in Saraca asoca (Roxb). De Wilde.J Non-Timber For Prod,11,34-35.
4. Bergmeyer, HV(ed.)(1974).Methods in Enzymatic Analysis.New York:Academic Press.
5. Bishayee, S,Balasubramanian, AS(1971).Lipid peroxide formation in rat brain.J Neurochem,18,909-920.
6. Dubey, NK,Rajesh, K,Pramila, T(2004).Global promotion of herbal medicine: India's opportunity.Curr Sci,86,37-41.
7. Dubey, RB,Savant, BS(2015).Current scenario of adulterants and substitutes of medicinal plants: a review.J Pharm Sci Innov,4(5),247-250.
8. Elizabeth, K,Rao, MNA(1990).Oxygen radical scavenging activity of Curcumin.Int J Pharm,58,237-240.
9. Firmin-Gomes-Teixeira, Z,Anthonioz, P(1989).Estrogens induce malpighian meta-plasia of the endo- cervical junction in female rats immunohistochemistry study.Biol Struct Morphog,2(2),45-53.
10. Javarappa, KK,Prasad, AGD,Prasad, AJM,Mane, C(2016).Bioactivity of diterpens from the ethyl acetate extract of Kingiodendron pinnatum Rox.Hams Pharmacogn Res,8(4),287-291.
11. Joshi, PR,Patel, BR,Shukla, VJ(2012).An overview of the causes of current practices in Pratinidhi Dravyas (substitution of drugs) in Ayurveda including newer techniques for their evaluation.Ayu,33(4),481-485.
12. Kamat, SK,Barde, PJ,Raut, SB.(2015).Evaluation of the estrogenic activity of Indian medicinal plants in immature rats.Anc Sci Life,35(2),90-95.
13. Katz, VL(ed.),Lentz, GM(ed.),Lobo, RA(ed.),Gershenson, DM(ed.)(2007).Comprehensive Gynecology.Philadelphia, Pa:Mosby Elsevier.
14. Kumar, JK,Prasasd, AGD,Richard, SA(2011).Biochemical activity of endangered medicinal plant K. Pinnatum.Asian J Plant Sci Res,1(4),70-75.
15. Marjoribanks, J,Proctor, M,Farquhar, C,Derks, RS(2010).Non-steroidal anti-inflammatory drugs for dysmenorrhoea.Cochrane Database Syst Rev,1,CD001751.
16. McCord, JM,Fridovich, I(1969).Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein).J Biol Chem,244,6049-6055.
17. Middelkoop, TB,Labadie, RP(1983).Evaluation of Asokarishta, an indigenous medicine in Sri Lanka.J Ethnopharmacol,8(3),313-320.
18. Mishra, L,Singh, BB,Dagenais, S(2001).Ayurveda: a historical perspective and principles of the traditional healthcare system in India.Altern Ther Health Med,7(2),36-42.
19. Modi, MB,Donga, SB,Dei, L(2012).Clinical evaluation of Ashokarishta, Ashwagandha Churna and Praval Pishti in the management of menopausal syndrome.Ayu,33(4),511-516.
20. Moron, MA,Depierre, JW,Manner, Mannervick B(1979).Levels of glutathione, glutathione reductase and glutathione-S-transferase activities in rat liver.Biochimica et Biophysica Acta,582,67-68.
21. Mukherjee, PK,Harwansh, RK,Bahadur, S(2016).Development of Ayurveda -tradition to trend.J Ethnopharmacol,30782-30786.
22. Ohkawa, H,Ohishi, W,Yagi, K(1979).Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction.Biochemistry,95,351-358.
23. Panchawat, S,Sisodia, SS(2010).In vitro antioxidant activity of Saraca asoca roxb. De Wilde stem bark extracts from various extraction processes.Asian J Pharm Clin Res.,3(3),231-233.
24. Patwardhan, B(2000).Ayurveda: the designer medicine.Indian Drugs,37,213-227.
25. Polaneczky, MM,Slap, GB(1992).Menstrual disorders in the adolescent: dysmenorrhea and dysfunctional uterine bleeding.Pediatr Rev.,13(3),83-87.
26. Poornima, B(2010).Adulteration and substitution in herbal drugs a critical analysis.Int J Res Ayurveda Pharm,1(1),8-12.
27. Pradhan, P,Joseph, L,Gupta, V(2009).Saraca asoca (Ashoka): a review.J Cheml Pharm Res,1(1),62-71.
28. Sadhu, SK,Khatun, A,Phattanawasin, P,Ohtsuki, T,Ishibashi, M(2007).Lignan glycosides and flavonoids from Saraca asoca with antioxidant activity.J Nat Med.,61,480-482.
29. Shahid, AP,Salini, S,Sasidharan, N,Padikkala, J,Raghavamenon, AC,Babu, TD(2015).Effect of Saraca asoca (Asoka) on estradiol induced keratinizing metaplasia in rat uterus.J Basic Clin Physiol Pharmacol.,26(5),509-515.
30. Sheik, S,Chandrashekar, KR(2014).Antimicrobial and antioxidant activities of King-iodendron pinnatum (DC.) Harms and Humboldtia brunonis Wallich: Endemic plants of the Western Ghats of India.J Natn Sci Found Sri Lanka,42(4),307-313.
31. Shukla, R,Chakravarty, M,Gautam, MP(2008).Indigenous medicine used for treatment of gynecological disorders by tribal of Chhattisgarh, India.J Med Plant Res,2(12),356-360.
32. Subrat, N,Iyer, M,Prasad, R.(2002).The Ayurvedic Medicine Industry: Current Status and Sustainability.New Delhi:Ecotech Services (India) Pvt. Ltd.
33. Tewari, DN(1999).Report of the Task Force on Conservation and Sustainable Use of Medicinal Plants.Govt. of India.
34. Vaidya, ADB,Devasagayam, TPA(2007).Current status of herbal drugs in India: an overview.J Clin Biochem Nutr,41(1),1-11.
35. Wallace, S,Keightley, A,Gie, C(2010).Review dysmenorrhea.TOG,12(3),149-154.
36. Warrier, PK,Nambier, VPK,Ganpathy, PM(2000).Some Important Medicinal Plants of the Western Ghats, India: A Profile.New Delhi:International Development Research Centre.
37. WHO(2000).General Guidelines for Methodologies on Research and Evaluation of Traditional Medicine.Geneva:World Health Organization.
38. Winter, CA,Risley, EA,Nuss, GW(1962).Carrageenan induced edema in hind paw of the rat as an assay for anti-inflammatory drugs.Proc Soc Exp Biolmed,111,544-547.
39. Zhang, Q,Shen, Q,Celestino, J(2009).Enhanced estrogen-induced proliferation in obese rat endometrium.Am J Obstet Gynecol,200(2),186.